![Vertex Pharmaceuticals Incorporated Website](https://finchat.io/assets/logos/36235.png)
Vertex Pharmaceuticals Incorporated
NasdaqGS-VRTX
Basic
Market Cap
$127.03B
EV
$113.2B
Shares Out
258.05M
Revenue
$10.19B
Employees
5,400
Margins
Gross
55.35%
EBITDA
45%
Operating
43.2%
Pre-Tax
46.81%
Net
39.46%
FCF
36.5%
Returns (5Yr Avg)
ROA
22.42%
ROTA
31.63%
ROE
30.53%
ROCE
30.16%
ROIC
70.54%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$483.26
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$10.17B
Net Debt
-$13.83B
Debt/Equity
0.04
EBIT/Interest
102.08
Growth (CAGR)
Rev 3Yr
16.66%
Rev 5Yr
25.55%
Rev 10Yr
26.1%
Dil EPS 3Yr
13.67%
Dil EPS 5Yr
13.18%
Dil EPS 10Yr
25.3%
Rev Fwd 2Yr
8.84%
EBITDA Fwd 2Yr
12.98%
EPS Fwd 2Yr
9.21%
EPS LT Growth Est
30.17%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)